Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00010101 · ClinicalTrials.gov registry record
Genetic Study of Brain Tumors in Young Children
A clinical trial, sponsored by Pediatric Brain Tumor Consortium.
- Terminated
- Registry status
- 38
- Enrollment target
NCT00010101: Clinical Trial study, sponsored by Pediatric Brain Tumor Consortium.
NCT00010101 is a clinical trial that was terminated before completion, run by Pediatric Brain Tumor Consortium. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00010101 was terminated before completion, sponsored by Pediatric Brain Tumor Consortium.
- TERMINATED
- Registry status
- 38 participants
- Enrollment target
Study Summary
RATIONALE: Genetic studies may help in understanding the genetic processes involved in the development of some types of cancer. PURPOSE: Genetic study to understand how genes may be involved in the development of brain tumors in young children.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2001-03 |
| Est. Completion | 2004-08 |
Why NCT00010101 stopped before completion
NCT00010101 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 38 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00010101 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00010101 about?
NCT00010101 is a clinical study titled "Genetic Study of Brain Tumors in Young Children". RATIONALE: Genetic studies may help in understanding the genetic processes involved in the development of some types of cancer. PURPOSE: Genetic study to understand how genes may be involved in the development of brain tumors in young children.
What is the current status of trial NCT00010101?
This trial is currently terminated. The enrollment target is 38 participants. The study started on 2001-03. Estimated completion is 2004-08.
Who is sponsoring clinical trial NCT00010101?
This trial is sponsored by Pediatric Brain Tumor Consortium, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia